Wegovy is one of the most frequently denied medications in the country. It’s also one of the medications where patients have the most arguments available to fight back. Most patients have a case. The challenge is figuring out which one to make.

A Wegovy appeal letter that argues weight management when your denial is based on a blanket plan exclusion will fail. So will one that cites cardiovascular data when the insurer’s actual objection is a documentation gap. Wegovy’s FDA label now spans three distinct indications, and each one opens a different set of clinical, policy, and legal arguments. Your letter needs to match your evidence to your specific denial, or it’s wasted effort.

This guide walks through a proven appeal letter structure section by section, explains how to customize each part for your specific Wegovy denial, and covers what to do if the first response comes back unfavorable. We’ve also put together a free downloadable template to give you a starting point.

If you’d prefer not to build this from scratch, Claimable generates fully customized Wegovy appeal letters backed by a purpose-built database of clinical studies, insurer policies, and legal standards, then submits them directly to your insurer on your behalf.

Start Here: Identify Your Denial Type

Before writing anything, find the exact denial reason on your letter. The entire strategy changes depending on which barrier you’re facing, and submitting the wrong type of argument wastes time and appeal opportunities. Wegovy’s FDA label now covers chronic weight management, cardiovascular risk reduction, and MASH with liver fibrosis, which means a blanket “weight loss drug” exclusion doesn’t necessarily close the door.

Our guide to Wegovy denials breaks down each denial type, what it actually means, and the best first move for each, including when an alternate indication can bypass the denial entirely.

If the denial traces back to a correctable issue (a missing lab result, an outdated BMI measurement, or a wrong diagnosis code) you may not need a formal appeal at all. A resubmission with the missing documentation can sometimes resolve it faster.

Wegovy Appeal Letter: What to Include, Plus a Customizable Template

We’ve created a free, customizable appeal letter template you can use as a starting point for your Wegovy appeal:

Download the free appeal letter template

Each section of a strong Wegovy appeal serves a specific function. Here’s what to include and why.

Section 1: Identifying Information, Claim Details, and Denial Reference

Start with a header block that identifies you, your insurer’s appeals department, and the specific claim at issue. The opening paragraph should name the medication, the prescribing physician, your diagnosis, and the insurer’s stated denial reason, quoted directly from the letter. Reproducing their exact language matters. Everything that follows is a targeted response to that specific rationale.

If a gap in treatment poses a medical risk (disease progression, cardiovascular events, weight regain that worsens comorbidities), this is also where you request an expedited review. Most plans must decide expedited appeals within 72 hours.

Note your appeal deadline immediately. Most commercial plans allow 180 days for an internal appeal, but timelines vary by plan type and insurer. UnitedHealthcare allows just 65 days for many plan types. Medicare Advantage plans allow 60 days under CMS rules. ERISA employer plans and Medicaid each run on their own schedules, and some are considerably shorter.

Your exact deadline is printed on your denial letter. Mark your calendar the day the denial arrives and file as early as you can.

Section 2: Your Diagnosis and Its Impact on Your Life

This section establishes your clinical profile and makes the human cost of the denial concrete. Include your diagnosis with ICD-10 codes if available, all relevant comorbidities, and a specific description of how your condition affects daily life.

For Wegovy, the indication your prescriber documented matters enormously. If the prescription is for cardiovascular risk reduction, your appeal needs to center your cardiovascular history (prior heart attack, stroke, peripheral arterial disease) and the risk of being denied a medication with proven event reduction data. If it’s for MASH with liver fibrosis, the framing is hepatic, not metabolic.

If it’s for chronic weight management, the appeal should document the full clinical picture, including BMI, comorbidities, functional limitations, and the impact of obesity on your overall health trajectory.

A reviewer who reads that you’re managing heart failure, sleep apnea, or progressive liver disease reads the clinical sections that follow with a different frame than one who sees a vague reference to weight concerns.

Section 3: Prior Treatments and Their Outcomes

This section demonstrates that you’ve already done what the plan requires, or that there’s a documented clinical reason those requirements don’t apply to you. Present prior treatments in a clear table, with specific dates, drug names, and documented outcomes are what turn a general claim into evidence the insurer is required to address.

Two details that patients frequently overlook. First, “failure” includes intolerable side effects, medical contraindications, and results that didn’t reach or sustain a clinically meaningful threshold, not just complete non-response. Second, if you’re currently on Wegovy and responding well, the continuity of care argument (that switching or stopping would reverse clinical progress) belongs here as well.

Section 4: Why Wegovy Is Medically Necessary

This section connects your physician’s clinical judgment, your treatment history, and your current health trajectory into a single argument. It should explain why Wegovy specifically is the appropriate medication, not just “a GLP-1,” and what happens without it, such as disease progression, cardiovascular events, weight regain that worsens existing comorbidities, liver disease advancement, or loss of function.

Medical necessity is the standard most denials ultimately turn on, and the section should meet it directly. If your prescriber has written a letter of medical necessity, this section of your appeal letter reinforces and builds on that clinical reasoning with your own perspective and supporting evidence.

One detail for patients already on Wegovy that’s easy to miss. Use your baseline BMI from before starting treatment, not your current weight. Insurers have denied coverage based on improved numbers, essentially penalizing patients for responding to the medication. Your pre-treatment clinical picture is what establishes the need.

Section 5: Clinical Evidence Supporting Wegovy

This section does the heaviest lifting, and it’s where most generic appeal letters miss. Cite specific clinical trials, match each to your indication, and connect the data to the insurer’s stated reason for denial.

Match the trial data to your situation. Citing SELECT, a cardiovascular risk reduction trial, in a weight management appeal won’t strengthen your case. Citing weight management studies for a MASH-coded prescription misses the point. Use the trial that matches your indication.

A serious caution: never cite a study you haven’t verified. General-purpose AI tools and template letters routinely generate fabricated clinical references that look convincing. A single invented citation gives the reviewer a clean justification to dismiss your entire appeal. If you can’t produce a real citation for a claim, remove it.

Section 6: The Denial Doesn’t Align With Your Insurer’s Own Criteria

Insurers publish their Wegovy coverage policies, and those documents are publicly available. Pull the relevant policy, identify each criterion, and show point by point that your clinical profile satisfies them.

If the policy requires a BMI of 30 or above and your records show 34, say so. If the policy requires documented comorbidities and your chart lists three of them, list them against the criteria. If the policy requires prior treatment attempts and you’ve already completed them, show the match.

Section 7: Applicable State and Federal Law

Legal citations move your appeal from a request to a demand, and insurers treat those differently. The specific protections available depend on your plan type and your state, but they often include ACA-guaranteed rights to internal appeal and independent external review, state step therapy override laws, and ERISA protections for employer-sponsored plans. Several states now mandate coverage for FDA-approved anti-obesity medications, and if yours is one of them, that belongs in this section.

If your plan excludes weight loss drugs but covers cardiovascular treatment, and you have an established cardiovascular condition, the argument that Wegovy’s CV indication falls outside the weight loss exclusion is both a clinical argument and a legal one. The same applies to MASH, which is a liver disease indication that is categorically different from a weight management one, and your appeal should make that distinction explicit.

Section 8: Request for Review and Approval

Close with a formal, specific request. Ask the insurer to approve coverage for Wegovy, override the cited denial barrier, and if the situation is time-sensitive, process the appeal on an expedited basis. Ask for written confirmation of the decision. If the appeal is denied, request the complete claim file so you can see every document the reviewer considered and identify any gaps for the next level of review.

Section 9: Supporting Documentation

List everything you’re including with the letter, such as the physician’s letter of medical necessity, medical records documenting your diagnosis and treatment history, relevant lab results, the clinical studies cited in the letter, the original denial letter, and any prior appeal decisions. Nothing should require the reviewer to go searching.

Section 10: Citations and References

End with a full reference list of every clinical trial, guideline, insurer policy, and statute cited. This doubles as your own quality check. If you can’t produce a clean, verifiable citation for a claim, that claim should not be in the letter.

An Alternative Approach: Use Claimable

The template above provides the architecture of a strong appeal. But the sections that determine whether it succeeds (clinical evidence, policy analysis, legal citations) are also the ones that require hours of targeted research and where errors weaken your case. A misquoted trial or a misapplied statute does more harm than leaving the section blank.

Claimable does this work for you. You answer a set of questions about your denial, your diagnosis, and your treatment history, and Claimable generates a fully personalized appeal drawing on a specialized database of verified clinical studies, insurer-specific policies, and applicable law. Every citation is verified, every argument is matched to your insurer and plan type, and we mail and fax it directly to your plan on your behalf.

Over 80% of Claimable appeals succeed, with most resolved in 10 days or less. Appealing with Claimable costs $39.95 for Wegovy, with no success fees and no hidden costs.

Start your Wegovy appeal with Claimable.

Common Mistakes That Get Wegovy Appeals Denied

Building the Appeal Around the Wrong Indication

Wegovy’s multi-indication label is an asset, but only if you’re using the one that fits your clinical profile. An appeal that argues cardiovascular risk reduction without documenting established cardiovascular disease won’t land. One that argues weight management when a MASH-coded prescription would bypass the plan exclusion entirely is a missed opportunity. Before drafting, identify which indication gives you the strongest case given your clinical profile and your denial type, and build the entire letter around it.

Using Current Weight Instead of Baseline BMI

If you’ve already been on Wegovy and lost weight, your current BMI may no longer meet the plan’s threshold. That’s the medication working, not a reason to deny coverage. Your appeal should document your pre-treatment baseline, not the number on the scale today. This is a common and avoidable mistake that hands the insurer an easy rationale.

Vague Language That Doesn’t Engage With the Denial

A letter that says “my doctor says I need this medication” without clinical specifics gives the reviewer nothing to evaluate. Spell out your disease activity, your comorbidities, your prior treatments and exactly why they were insufficient, and the precise clinical reasoning for Wegovy over alternatives. Personal impact belongs in the letter, but it reinforces the clinical evidence rather than replacing it.

Citing Fabricated Studies or Incorrect Legal References

General-purpose AI tools generate convincing-looking clinical citations that don’t exist and legal references that don’t say what the letter claims. A reviewer who catches one fabricated source has every reason to treat the entire submission as unreliable. Verify every reference before it goes near your insurer. This is exactly why Claimable runs on a proprietary database of real, verified sources rather than a general-purpose language model.

Missing the Filing Deadline

Deadlines are printed on your denial letter and they are absolute. Most commercial plans allow 180 days for an internal appeal, but not all do. UnitedHealthcare gives just 65 days for many plan types. Medicare Advantage plans allow 60 days under current CMS guidelines.

Missing the window eliminates your right to appeal entirely. Mark the deadline the day the letter arrives and file with as much lead time as possible.

Don’t Navigate This Alone If You Don’t Have To

You have the legal right to appeal, the clinical evidence to support it, and a process designed to give you multiple chances to make your case. The template above gives you the structure to build a strong Wegovy appeal on your own.

If you’d rather not spend hours verifying clinical studies and tracking down insurer policies, Claimable handles the research-intensive work, builds an appeal customized to your insurer and plan type, and submits it on your behalf. Over 80% of our appeals succeed, with most resolved in 10 days or less.

Start your Wegovy appeal with Claimable.